Management of Hepatic Encephalopathy: Role of Rifaximin

Publisher： Karger

E-ISSN： 1421-9794|51|1|90-95

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.1, 2005-04, pp. : 90-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Diverticular Disease: Is There Room for Rifaximin?

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 110-114

Karger

Access to resources Recommend Favorite

Resveratrol in Patients with Minimal Hepatic Encephalopathy

By Malaguarnera Giulia   Pennisi Manuela   Bertino Gaetano   Motta Massimo   Borzì Antonio Maria   Vicari Enzo   Bella Rita   Drago Filippo   Malaguarnera Michele  

Nutrients, Vol. 10, Iss. 3, 2018-03 ,pp. : 329-329

MDPI

Access to resources Recommend Favorite

Contributions of Microdialysis to New Alternative Therapeutics for Hepatic Encephalopathy

By Rivera-Espinosa Liliana   Floriano-Sánchez Esaú   Pedraza-Chaverrí José   Coballase-Urrutia Elvia   Sampieri Aristides   Ortega-Cuellar Daniel   Cárdenas-Rodríguez Noemí   Carmona-Aparicio Liliana  

International Journal of Molecular Sciences, Vol. 14, Iss. 8, 2013-08 ,pp. : 16184-16206

MDPI

Access to resources Recommend Favorite

Management of Inflammatory Bowel Disease: Does Rifaximin Offer Any Promise?

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 96-102

Karger

Access to resources Recommend Favorite

Rifaximin in the Treatment of Infectious Diarrhea

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 73-80

Karger

Access to resources Recommend Favorite